The genomic landscape of CYP2D6 variation in the Indian population

被引:0
|
作者
Sivadas, Ambily [1 ]
Rathore, Surabhi [2 ,3 ]
Sahana, S. [2 ,3 ]
Jolly, Bani [2 ,3 ]
Bhoyar, Rahul C. [2 ]
Jain, Abhinav [2 ,3 ]
Sharma, Disha [2 ]
Imran, Mohamed [2 ,3 ]
Senthilvel, Vigneshwar [2 ,3 ]
Divakar, Mohit Kumar [2 ,3 ]
Mishra, Anushree [2 ,3 ]
Sivasubbu, Sridhar [2 ,3 ,4 ]
Scaria, Vinod [2 ,3 ,4 ]
机构
[1] St Johns Natl Acad Hlth Sci, Div Nutr, St Johns Res Inst, Bangalore 560034, Karnataka, India
[2] CSIR, Inst Genom & Integrat Biol, Mathura Rd, New Delhi 110025, India
[3] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, Uttar Pradesh, India
[4] Vishwanath Canc Care Fdn, B 702,7th Floor,Neelkanth Business Pk Kirol Villag, Vidya Vihar 400086, West Mumbai, India
关键词
cytochrome P450; drug metabolism; genomics; Indian population; molecular dynamics simulation; personalized medicine; pharmacogenomics; pharmacology; polymorphism; DRUG-METABOLIZING-ENZYMES; GENETIC-POLYMORPHISM; POOR METABOLIZERS; CRYSTAL-STRUCTURE; IN-SILICO; WILD-TYPE; DEBRISOQUINE; VARIANTS; IDENTIFICATION; FREQUENCY;
D O I
10.2217/pgs-2023-0233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: The CYP2D6 gene is highly polymorphic, causing large interindividual variability in the metabolism of several clinically important drugs. Materials & methods: The authors investigated the diversity and distribution of CYP2D6 alleles in Indians using whole genome sequences (N = 1518). Functional consequences were assessed using pathogenicity scores and molecular dynamics simulations. Results: The analysis revealed population-specific CYP2D6 alleles (*86, *7, *111, *112, *113, *99) and remarkable differences in variant and phenotype frequencies with global populations. The authors observed that one in three Indians could benefit from a dose alteration for psychiatric drugs with accurate CYP2D6 phenotyping. Molecular dynamics simulations revealed large conformational fluctuations, confirming the predicted reduced function of *86 and *113 alleles. Conclusion: The findings emphasize the utility of comprehensive CYP2D6 profiling for aiding precision public health.
引用
收藏
页码:147 / 160
页数:14
相关论文
共 50 条
  • [1] The variation landscape of CYP2D6 in a multi-ethnic Asian population
    Maulana, Yusuf
    Jimenez, Rodrigo Toro
    Twesigomwe, David
    Sani, Levana
    Irwanto, Astrid
    Bertin, Nicolas
    Gonzalez-Porta, Mar
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [2] Resequencing CYP2D6 gene in Indian population: CYP2D6*41 identified as the major reduced function allele
    Manoharan, Aarthi
    Shewade, Deepak Gopal
    Ravindranath, Pradeep Anand
    Rajkumar, Ravi Philip
    Ramprasad, Vedam L.
    Adithan, Surendiran
    Damodaran, Solai Elango
    PHARMACOGENOMICS, 2019, 20 (10) : 719 - 730
  • [3] CYP2D6 phenotype and genotype in a Canadian Native Indian population
    Nowak, MP
    Tyndale, RF
    Sellers, EM
    PHARMACOGENETICS, 1997, 7 (02): : 145 - 148
  • [4] Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
    Abduljalil, K.
    Frank, D.
    Gaedigk, A.
    Klaassen, T.
    Tomalik-Scharte, D.
    Jetter, A.
    Jaehde, U.
    Kirchheiner, J.
    Fuhr, U.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 643 - 651
  • [5] CYP2D6 genotypes in a Japanese population:: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10
    Nishida, Y
    Fukuda, T
    Yamamoto, I
    Azuma, J
    PHARMACOGENETICS, 2000, 10 (06): : 567 - 570
  • [6] CYP2D6 genetic variation in Ugandans
    Jun Miura
    Celestino Obua
    Catherine Abbo
    Tomonori Tateishi
    Sunao Kaneko
    European Journal of Clinical Pharmacology, 2022, 78 : 155 - 157
  • [7] CYP2D6 genetic variation in Ugandans
    Miura, Jun
    Obua, Celestino
    Abbo, Catherine
    Tateishi, Tomonori
    Kaneko, Sunao
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (01) : 155 - 157
  • [8] CYP2D6: novel genomic structures and alleles
    Kramer, Whitney E.
    Walker, Denise L.
    O'Kane, Dennis J.
    Mrazek, David A.
    Fisher, Pamela K.
    Dukek, Brian A.
    Bruflat, Jamie K.
    Black, John L.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (10): : 813 - 828
  • [9] CYP2D6 polymorphism in a Gabonese population:: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype
    Panserat, S
    Sica, L
    Gérard, N
    Mathieu, H
    Jacqz-Aigrain, E
    Krishnamoorthy, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (01) : 121 - 124
  • [10] Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3,*4, and*6), and the metabolic capacity of CYP2D6 in Northern Iranian Population (Mazandaran)
    Shiran, Mohammad R.
    Soteh, Mohammad B. Hashemi
    Merat, Fatemeh
    Sarzare, Fatemeh
    Salehifar, Ebrahim
    DRUG METABOLISM REVIEWS, 2010, 42 : 260 - 261